After individual and group review, the Committee then provides cohesive feedback to the Board of Trustees of Reverse Rett. Their main role is to ensure that any work they recommend for funding meets AMRC research standards and aligns with the Reverse Rett Research Strategy.
The Reverse Rett Research Advisory Board comprises of professionals, including scientists, researchers and independent industry experts as well as patient voice representatives.
Reverse Rett Research Advisory Board
David Greatrex Ph.D. Chair
Dr Ben Lashbrooke, Patient Voice
John H. Sharpe, Chairman Reverse Rett Non-voting member
Dr Jay Shetty, Consultant Paediatric Neurologist, Royal Hospital for Children Edinburgh & Edinburgh University
Jatinder Singh, Ph.D. Independent Scientific Advisor
Joanna Tomlin, Patient Voice
Mark Walls, Patient Voice
Mrs Louise Wainwright, Animal Welfare Officer
Deputy Bioscience Support Facility Manager, Nottingham Trent University